Mereo BioPharma Group plc (MREO) stock
MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 1/30
$0.29+0.01 (+5.39%)
Close on Nov 18, 2026Market cap $46.20MP/E –Yield –
Mereo BioPharma operating margin
Operating margin is operating income as a percentage of revenue.
Mereo BioPharma's operating margin for the twelve months ending Dec 31, 2025 was -8021.4%. For fiscal 2025 it was -8021.4%, against -284.2% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -8021.4% | −7737.2 |
| FY2023 | Dec 31, 2023 | -284.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -777.3% | – |
| Q2 FY2025 | Jun 30, 2025 | -2099.8% | – |
| Q4 FY2023 | Dec 31, 2023 | -712.8% | – |
| Q2 FY2023 | Jun 30, 2023 | -9.0% | – |
See a number that looks wrong?